Galen HRT Ring Femring Will Be Approved By February Or March, CEO Predicts
Executive Summary
Galen's estradiol ring product Femring will be approved by FDA in February or March, CEO Roger Boissonneault said in an earnings call Feb. 11
You may also be interested in...
Galen Femring Includes HRT Class Labeling; Launch In June
Labeling for Galen's vaginal hormone therapy Femring follows the template established for Wyeth's Premarin family to incorporate the findings from NIH's Women's Health Initiative study
Galen Femring Includes HRT Class Labeling; Launch In June
Labeling for Galen's vaginal hormone therapy Femring follows the template established for Wyeth's Premarin family to incorporate the findings from NIH's Women's Health Initiative study
Hormone Therapy Class Labeling Uses Wyeth Template; Appeals Due By March
Sponsors of hormone replacement therapies have two months to pull together data to justify exemptions to FDA's proposed class labeling incorporating risk information from the Women's Health Initiative